Evaluation of clinical efficacy of traditional Chinese medicine in promoting nucleic acid conversion of new coronavirus Delta variant strain infectio

Not Applicable

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2100005148
• Lead Sponsor: Guangdong Provincial Hospital of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria for COVID-19 (National Eighth Edition);
2. Aged over 18 years;
3. Normal body temperature within 48 hours;
4. In the case of inhaling air, SpO2>93%;
5. Onset time >= 7 days;
6. Sign informed consent.

Exclusion Criteria

1. The nucleic acid test turns negative twice in a row (24 hours apart);
2. Those who meet the discharge criteria and have a positive nucleic acid re-test after discharge;
3. Those who are in critical condition and are expected to die within 24 hours;
4. Abnormal liver and kidney function (more than 2 times the normal value), or a history of severe arrhythmia, heart rate >= 120 beats/min;
5. Allergic to known traditional Chinese medicine;
6. Those who do not cooperate or cannot cooperate with taking traditional Chinese medicine;
7. Pregnant patients.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change of viral load;

Secondary Outcome Measures

Name	Time	Method
The ratio of main symptoms disappeared in 7 days/14 days;Whether there is a retest positive after the nucleic acid turns negative within 21 days;Hospital stays; 7-day/14-day nucleic acid conversion ratio; 7 days/14 days chest CT imaging changes;Nucleic acid negative time;Prognosis;